Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Coix seed extract composite tablets are solid dosage forms manufactured via spray drying or granulation of Coix lacryma-jobi L. extracts, often blended with excipients for stability. While the primary bioactive component is Coixolide (CAS 518-62-9), composite formulations lack a single unified CAS number due to variable proprietary blends.
Storage requires cool, dry conditions below 25°C to prevent moisture absorption. Clinical use is restricted for pregnant women and patients with specific kidney disorders; professional medical consultation is mandatory prior to therapeutic application.